Austin, TX, Nov. 14, 2023 (GLOBE NEWSWIRE) QSAM Biosciences Inc. (OTCQB: QSAM), a company developing therapeutic radiopharmaceuticals for the treatment of primary and secondary bone cancer and related conditions, has signed a non-binding term sheet (the “Term Sheet”) with Telix Pharmaceuticals (US) Inc., a subsidiary of Telix Pharmaceuticals Limited (ASX: TLX) (collectively, “Telix”) providing material terms for the acquisition of the Company by Telix by means of a merger (the “Acquisition”).
14.11.2023 - Austin, TX, Nov. 14, 2023 (GLOBE NEWSWIRE) - QSAM Biosciences Inc. (OTCQB: QSAM), a company developing therapeutic radiopharmaceuticals for the treatment of primary and secondary bone cancer and related conditions, has signed a non-binding term . Seite 1
Telix Pharmaceuticals announces local expansion thetimes24-7.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thetimes24-7.com Daily Mail and Mail on Sunday newspapers.
Cardinal Health Adds Muscle to Indy Nuclear Medicine Hub - Inside INdiana Business insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.